作者
Timothy R. Deer,Marc Russo,Jay S. Grider,Dawood Sayed,Tim J. Lamer,David Dickerson,Jonathan M. Hagedorn,Erika Petersen,Michael Fishman,James J. FitzGerald,Ganesan Baranidharan,Dirk De Ridder,Krishnan Chakravarthy,Adnan Al‐Kaisy,Corey Hunter,Eric Buchser,Kenneth B. Chapman,Christopher Gilligan,Salim M. Hayek,Simon Thomson,Natalie Strand,Jessica Katz Jameson,Thomas Simopoulos,Ajax Yang,Olivier De Coster,Fabián Cremaschi,Paul J. Christo,Vishal Varshney,Stana Bojanić,Robert M. Levy
摘要
Introduction The International Neuromodulation Society (INS) has recognized a need to establish best practices for optimizing implantable devices and salvage when ideal outcomes are not realized. This group has established the Neurostimulation Appropriateness Consensus Committee (NACC)® to offer guidance on matters needed for both our members and the broader community of those affected by neuromodulation devices. Materials and Methods The executive committee of the INS nominated faculty for this NACC® publication on the basis of expertise, publications, and career work on the issue. In addition, the faculty was chosen in consideration of diversity and inclusion of different career paths and demographic categories. Once chosen, the faculty was asked to grade current evidence and along with expert opinion create consensus recommendations to address the lapses in information on this topic. Results The NACC® group established informative and authoritative recommendations on the salvage and optimization of care for those with indwelling devices. The recommendations are based on evidence and expert opinion and will be expected to evolve as new data are generated for each topic. Conclusions NACC® guidance should be considered for any patient with less-than-optimal outcomes with a stimulation device implanted for treating chronic pain. Consideration should be given to these consensus points to salvage a potentially failed device before explant.